Dr. Khan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-4673Fax+1 214-645-2661
Summary
- Dr. Adeel Khan is an Oncologist based in Dallas, TX with a subspecialty in Hematologic Oncology. His educational background begins with a Bachelors in Mathematics and Psychology from the University of Oklahoma, followed by Master's degrees in Epidemiology and Public Health from the Columbia University Mailman School of Public Health and Harvard T. H. Chan School of Public Health, respectively. He then completed his Residency in Internal Medicine at Cleveland Clinic Foundation and Fellowship in Hematology and Medical Oncology at Beth Israel Deaconess Medical Center. He currently serves as an Assistant Professor at The University of Texas Southwestern Medical Center. His publications have been featured in a number of esteemed journals such as Hematological Oncology, The Oncologist, and The Lancet Oncology.
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
- Columbia University Mailman School of Public HealthMS, Executive Program in Epidemiology, 2017 - 2019
- Cleveland Clinic FoundationResidency, Internal Medicine, 2014 - 2017
- University of Michigan Medical SchoolClass of 2014
- Harvard T. H. Chan School of Public HealthMPH, Quantitative Methods, 2012 - 2013
- University of OklahomaBA, Mathematics, Psychology, 2003 - 2007
Certifications & Licensure
- MA State Medical License 2017 - 2025
- TX State Medical License 2022 - 2025
- OH State Medical License 2014 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 1 citationsOutcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy.Danai Dima, Utkarsh Goel, Aishwarya Sannareddy, Nnaemeka Ibeh, Fauzia Ullah
Hematological Oncology. 2024-07-01 - 5 citationsSurvival outcomes with warfarin compared with direct oral anticoagulants in cancer-associated venous thromboembolism in the United States: A population-based cohort st...Adeel M Khan, Thita Chiasakul, Robert Redd, Rushad Patell, Ellen P McCarthy
Plos Medicine. 2022-05-01 - A Cancer by Any Other Name.Adeel M Khan
The Oncologist. 2021-10-01
Journal Articles
- A Cancer by Any Other NameKhan AM, The Oncologist, 10/9/2021
Press Mentions
- Cancer-Causing Chemical Was Found in These Diabetes Medications: Merck Says They Can Fix ItJanuary 20th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: